Interim Report for January-September 2026

Terveystalo will host an English-language results webcast and conference call on the same day at 10:30 a.m. EEST. The webcast can be followed at:

https://terveystalo.events.inderes.com/q3-2026

Conference call: https://events.inderes.com/terveystalo/q3-2026/dial-in

To participate in the conference call, please register via the link above. After registration, you will receive a phone number and conference ID to access the call.

Progress of the ARC strategy and Oral Health

As part of the Q3/2026 results webcast, Terveystalo will provide a brief update on the execution of the ARC strategy. In addition, Ville Pesonen, SVP, Oral Health, will introduce himself to investors and provide an overview of the Oral Health business following the completion of the Hohde Group acquisition in September 2026.

Capital Markets Day rescheduled

Terveystalo has decided to postpone its previously planned Capital Markets Day from December 2026 to spring 2027.
The purpose of the postponement is to ensure that the company can provide a comprehensive update on the execution of its ARC strategy, the development of its key growth platforms and the impact of its strategic transactions. The planned Silmäasema transaction is a key element of the ARC strategy, and Terveystalo believes that hosting the Capital Markets Day after completion of the transaction will enable the company to provide investors with a clearer view of strategy execution, the development of its growth platforms and the long-term value creation potential of the combined business. Terveystalo will announce the exact date of the Capital Markets Day at a later stage.